Director

Home > Director

Sajita Setia

Dr Sajita Setia, MD is a clinical biochemist and pharmaceutical physician, certified by King’s College, London. Prior to starting Transform Medical Communications, Sajita was Head of Medical Affairs for a pharmaceutical company in Singapore. A physician by training, she has spent over 18 years in healthcare including ten years in the pharmaceutical industry. She has authored numerous scientific manuscripts and textbooks for medical students and published many clinical papers in collaboration with regional and global key opinion leaders while working in medical affairs. Sajita also acts as a reviewer for several peer-reviewed journals and has won many awards in academia and pharma. Sajita has served in a variety of roles in healthcare, ranging from clinical educator to medical lead in pharma and has created a strong legacy of value creation through publications and strong partnerships with government, regulatory agencies, medical societies and associations. At Transform Medical Communications, Sajita continues to provide independent medical affairs expertise and consultation.

Sajita is also mental health and positive psychology enthusiast and founder of Transforming Life https://www.transforming-life.com/ – a digital platform to boost mental health and emotional well-being using scientific and proven metacognitive insights, knowledge, and practices. She trains individuals and teams to achieve a sound control over their thoughts, feelings, and emotions by empowering them with profound skill sets that provide happiness, bliss, productivity, and success irrespective of life’s challenges.

Sajita has authored several medical publications across multiple therapeutic areas; below are a few selected key publications:

  1. Shau WY, Setia S, Chen YJ, et al. Integrated Real-World Study Databases in 3 Diverse Asian Health Care Systems in Taiwan, India, and Thailand: Scoping Review. J Med Internet Res. 2023;25:e49593.
  2. Shau WY, Setia S, Shinde S, Santoso H, Furtner D. Generating fit-for-purpose real-world evidence in Asia: How far are we from closing the gaps?. Perspect Clin Res. 2023;14(3):108-113.
  3. Rajappa S, Singh M, Uehara R, Schachterle SE, Setia S. Cancer incidence and mortality trends in Asia based on regions and human development index levels: an analyses from GLOBOCAN 2020. Curr Med Res Opin. 2023;39(8):1127-1137.
  4. Shau WY, Setia S, Shinde SP, Santoso H, Furtner D. Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review. JMIR Res Protoc. 2022;11(12):e43741.
  5. Setia S, Furtner D, Bendahmane M, Tichy M. Success4life Youth Empowerment for Promoting Well-being and Boosting Mental Health: Protocol for an Experimental Study. JMIR Res Protoc. 2022;11(9):e38463.
  6. Furtner D, Shinde SP, Singh M, Wong CH, Setia S. Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond. Pharmaceut Med. 2022 Feb;36(1):1-10.
  7. Setia S, Krägeloh C, Bandyopadhyay G, Subramaniam K. Inculcating Dispositional Optimism for Prevention of Mental and Substance Use Disorders Throughout and After the Coronavirus Disease-19 Pandemic. Alternative and Complementary Therapies. 2021 April 12:68-78.
  8. Setia S, Tay JC, Chia YC, Subramaniam K. Massive open online courses (MOOCs) for continuing medical education – why and how? Adv Med Educ Pract. 2019;10:805–812. 
  9. Tham TY, Tran TL, Prueksaritanond S, Isidro JS, Setia S, Welluppillai V.Integrated health care systems in Asia: an urgent necessity. Clin Interv Aging. 2018;13:2527-2538.
  10. Setia S, Ryan NJ, Nair PS, Ching E, Subramaniam K. Evolving role of pharmaceutical physicians in medical evidence and education. Adv Med Educ Pract. 2018;9:777-790.
  11. Chadachan VM, Ye MT, Tay JC, Subramaniam K, Setia S. Understanding short-term blood-pressure-variability phenotypes: from concept to clinical practice. Int J Gen Med. 2018;11:241-254.
  12. Yeoh SF, Lee TJ, Chew KL, Lin S, Yeo D, Setia S. Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation. Infect Drug Resist. 2018;11:805-819.
  13. Lansberg P, Lee A, Lee ZV, Subramaniam K, Setia S. Nonadherence to statins: individualized intervention strategies outside the pill box. Vasc Health Risk Manag. 2018;14:91-102.
  14. Low Y, Setia S, Lima G. Drug-drug interactions involving antidepressants: focus on desvenlafaxine. Neuropsychiatr Dis Treat. 2018;14:567-580.
  15. Gwee KA, Goh V, Lima G, Setia S. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. J Pain Res. 2018;11:361-374.
  16. Setia S, Subramaniam K, Tay JC, Teo BW. Hypertension and blood pressure variability management practices among physicians in Singapore. Vasc Health Risk Manag. 2017;13:275-285.
  17. Setia S, Subramaniam K, Teo BW, Tay JC. Ambulatory and home blood pressure monitoring: gaps between clinical guidelines and clinical practice in Singapore. Int J Gen Med. 2017;10:189-197.
  18. Setia S, Fung SS, Waters DD. Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vasc Health Risk Manag. 2015;11:303-10.
  19. Eng P, Lim LH, Loo CM, Low JA, Tan C, Tan EK, Wong SY, Setia S. Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore. Int J Gen Med. 2014;7:179-91.
  20. Gwee KA, Setia S. Demographics and health care seeking behavior of Singaporean women with chronic constipation: Implications for therapeutic management. International Journal of General Medicine 2012:5;287–302.
  21. Setia S, Sridhar MG, Bhat V, Chaturvedula L, Vinayagamoorti R, John M. Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology 2006; 38: 236-8.
  22. Setia S, Sridhar MG, Koner BC, Bobby Z, Bhat V, Chaturvedula L. Increased insulin sensitivity in intrauterine growth retarded newborns- Do thyroid hormones play a role? ClinicaChimica Acta. 2007; 376:37-40.
  23. Sridhar MG, Setia S, John M, Bhat V, Nandeesha H, Sathiyapriya V. Oxidative stress varies with the mode of delivery in intrauterine growth retardation: association with APGAR score. Clinical Biochemistry. 2007; 40: 688-691.
  24. Setia S, Sridhar MG, Bhat V, Chaturvedula L. Growth hormone in IUGR newborns. Indian Journal of Pediatrics. 2007; 74: 13-16.
  25. Gupta A, Srinivasan R, Kaliaperumal S, Setia S. Microbial cultures in open globe injuries in southern India. Clinical and Experimental Ophthalmology 2007; 35: 432-438.
  26. Kaliaperumal S, Setia S, Gupta A, Rao VA. Fetal Birth Weight Blood Pressure: Association with Preeclamptic Retinopathy. European journal of ophthalmology. 2008; 18: 809-812.
  27. Gupta A, Kaliaperumal S, Setia S, Suchi ST, Rao VA. Retinopathy in Preeclampsia: Association with Birth Weight and Uric Acid. Journal of Retina. 2008; 28: 1104-110.
  28. Bobby Z, Nandeesha H, Sridhar MG, Koner BC, Renuka P, Setia S, Kumaran SS, Mawlong A. Formulation of questions followed by small group discussion: a learning method for medical students. National Medical Journal of India. 2008; 21: 261-262.
  29. Gupta A, Srinivasan R, Setia S, Soundravally R, Pandian DG. Uveitis following dengue fever. Eye. 2009; 23:873-876.
  30. Setia S, Sridhar MG. Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming? Hormone and Metabolic Research. 2009; 41:791-798.
  31. Soundravally R, Narayanan P, Bhat V, Soundraragavan J, Setia S. Fulminant hepatic failure: an atypical presentation of dengue infection. Indian Journal of Pediatrics. 2010; 77: 435-437.
  32. Gupta A, Srinivasan R, Babu KR, Setia S. Comparison of the clinical presentation and visual outcome in open globe injuries in adults and children over thirty months. European Journal of Ophthalmology. 2010; 20: 590-595.